Skip to main content
OpenTrials

Clinical trial condition

Type 2 Diabetes Mellitus

Explore clinical trials studying Type 2 Diabetes Mellitus. Study availability and eligibility vary by location and protocol.

1,509 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Type 2 Diabetes Mellitus trial results

Completed

Safety and Efficacy of LX4211 With Metformin in Type 2 Diabetes Patients With Inadequate Glycemic Control on Metformin

NCT01376557

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Lexicon Investigational Site Anaheim, California, United States
  • Lexicon Investigational Site Carmichael, California, United States
  • Lexicon Investigational Site Greenbrae, California, United States
  • Lexicon Investigational Site La Jolla, California, United States
View all 56 locations
View Trial Details
Completed

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

NCT01472185

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Thunderbird Internal Medicine/Clinical Research Advantage Glendale, Arizona, United States
  • Central Phoenix Medical Clinic Phoenix, Arizona, United States
  • Desert Sun Clinical Research, LLC Tucson, Arizona, United States
  • Eclipse Clinical Research Tucson, Arizona, United States
View all 159 locations
View Trial Details
Completed

A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes Mellitus

NCT01584232

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
View all 15 locations
View Trial Details
Completed

An Open-label, Multi-center, International, Three-year, Safety and Tolerability 'Follow on' Trial

NCT00754624

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Dorothy L & James E Frank Diabetes Research Institute San Mateo, California, United States
  • Sansum Medical Research Institute Santa Barbara, California, United States
  • Alliance Medical Group of Greater Waterbury Middlebury, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
View all 40 locations
View Trial Details
Completed

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

NCT01555164

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Fundamental Research LLC Gulf Shores, Alabama, United States
  • KLR Business Group DBA Arkansas Clinical Research Little Rock, Alaska, United States
  • Radiant Research, Inc. Chandler, Arizona, United States
  • Central Phoenix Medical Clinic Phoenix, Arizona, United States
View all 146 locations
View Trial Details

Related conditions